chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 9.0
Sex: U
Vaccine: FLU3, VARCEL
Symptoms: Dyspnoea, Face oedema, Livedo reticularis, Wheezing
Clinical narrative: Information has been received from a physician concerning a memo from their cooperate office regarding a nine year old patient who had received a varicella virus vaccine live (Oka/Merck) booster. It was reported that the patient developed a possible anaphylaxis reaction with wheezing, shortness of breath, facial edema, facial mottling, was stabilized and transported to the hospital. It was not specified if the patient was admitted. Current patient status was not reported. No product quality complaint was reported. Further information was not available. This is one of three reports from the same source. Additional information has been requested.
Age: 9.0
Sex: U
Vaccine: FLUN3, VARCEL
Symptoms: Dyspnoea, Face oedema, Livedo reticularis, Wheezing
Clinical narrative: Information has been received from a physician concerning a memo from their cooperate office regarding a nine year old patient who had received a varicella virus vaccine live (Oka/Merck) booster. It was reported that he developed a possible anaphylaxis reaction with wheezing, shortness of breath, facial edema, facial mottling, was stabilized, and transported to the hospital. It was not reported if the patient was admitted. Current patient status was not reported. No product quality complaint was reported. Further information was not available. This is one of three reports from the same source. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a medical assistant concerning her son who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient developed a full blown case of chickenpox. The patient recovered on an unspecified date. A product quality complaint was not involved. Additional information has been requested.
Age: 2.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 9 year old male who on 15-FEB-2007 was vaccinated with a single dose series of varicella virus vaccine live (Oka/Merck). On 10-OCT-2007, the patient came into the office and had a rash and experienced pain on his right leg. The physician reported that the patient was diagnosed with shingles. At the time of report the patient had recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is one of several reports received from the same source.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin test, Varicella post vaccine
Clinical narrative: Information has been received from a physician concern a 9 year old male who on 15-FEB-1997 was vaccinated with a single dose series of varicella virus vaccine live (Oka/Merck). On 10-OCT-2007 the patient came into the office and had a rash all over his body and had a fever. The physician performed a TZANCK test and the test came back positive. The physician reported that it was a break through of varicella. At the time of report the patient had recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is one of several reports received from the same source.
Age: 1.6
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 11 year old bi-racial male with environmental allergies, amoxicillin allergy, asthma and reactive airway symptoms who on 24-APR-1998 was vaccinated in the arm with the first dose of varicella virus vaccine live (Oka/Merck) (lot# 625046/1569E). On 06-NOV-2007 "not quite 10 years after varicella", the patient developed a full blown case of varicella with many skin lesions, no fever, and little to no itching. There were no other complications at 3 days into infection. At the time of report the patient's full blown case of varicella was still in an acute phase. The patient's outcome is unknown. Follow up information was received from a physician who reported that on 06 DEC 2007 the patient had completely recovered.
Age: 26.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a consumer concerning her 26-year-old son with no pertinent medical history or allergies who on 04-NOV-2007 was vaccinated subcutaneous with 0.5 mL dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On 18-NOV-2007, the patient "broke out with three chickenpox lesions and now has five". The patient did not seek medical attention and did not have any diagnostic labs performed. At the time of the report the patient's status was not recovered. A product quality complaint was not involved. No further information is available.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 13 year old male who on 12-JUN-1997 was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck). On 31-OCT-2007, the patient experienced approximately 50 lesions. Unknown medical attention was sought. On 13-NOV-2007, the patient recovered from lesions. No product complaint was involved. Additional information has been requested.
Age: 1.4
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a health professional concerning a 21 month old male with peanut allergy who on 12-JUN-1997 was vaccinated with varicella virus vaccine live (Oka/Merck). On 31-OCT-1997, the patient experienced approximately 50 lesions. On 13-Nov-1997, the patient recovered from lesions. Additional information has been requested.
Age: 43.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 43 year old male with an allergy to peanut butter and a history of negative titer for varicella (0.91), who on 06-NOV-2007, was vaccinated in the right deltoid with varicella virus vaccine live (Oka/Merck) (lot#654752/1257F). On 17-NOV-2007, it was reported that the patient developed a chickenpox like rash that started on his chest, moved to the back and to the arms, neck and face. It was reported that he had over 100 lesions and the rash was described as papules. It was reported that some of the papules were scabbing over. There was no reported fever. The patient had no previous vaccination history. It was reported that the patient sought unspecified medical attention and was to be followed by the physician. At the time of this report, the patient was reported as recovering. A product quality complaint was not reported. Additional information has been requested.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Cellulitis
Clinical narrative: Information has been received from a physician concerning an 11 year old male who on an unspecified date was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (lot# 658288/1174U). It was reported that on an unspecified date after receiving the vaccine, the patient developed cellulitis in the arm. The patient sought treatment in an emergency department. It was not specified if the patient was hospitalized. It was reported that on an unspecified date the patient had recovered. A product quality complaint was not reported. This is one of three reports from the same source. Additional information has been requested.
Age: 72.0
Sex: F
Vaccine: FLU3, VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a health professional concerning a 72 year old 159 lb. 67 1/2 in. female with a history of allergies to Relafen who "10 days ago" (17-OCT-2007), was vaccinated with a single dose in the right deltoid of varicella virus vaccine live (Oka/Merck) (lot#/ 658287/1173U), but was supposed to have been given zoster vaccine live (Oka/Merck). Concomitant vaccination included a dose in the left deltoid of Fluzone (lot# U2441AA). There was no reported illness at the time of vaccination or adverse events following prior vaccination. It was indicated that the patient did not develop any adverse experience as a result of the vaccination. There were no relevant diagnostic tests or laboratory data. Medical attention sought and current patient status was not reported. A quality complaint was not reported. Additional information is not expected.
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a physician concerning a 12 month old patient (gender not reported) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On an unspecified date (12 days post vaccination), the patient developed a "mild" case of chicken pox. The patient's status was not reported. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Dysmorphism, Pruritus generalised, Rash generalised, Rash vesicular, Skin disorder
Clinical narrative: Information has been received from a physician and registered nurse concerning a 13 year old 140 lb 64 in white female with spinal asymmetry, and no known allergies or birth defects, who on 06-NOV-2007 at 11:00 hours received a second subcutaneous dose in the right arm of varicella virus vaccine live (Oka/Merck) (lot#658423/1180U). Concomitant vaccination included a first dose intramuscularly in the left arm of hepatitis A vaccine (inactive) (MSD) (lot# 659187/1259U). There was no concomitant medication. There was no reported illness at the time of the vaccinations and no adverse events following prior vaccination. It was reported that on 06-NOV-2007, she developed a mild varicella like rash which persisted and progressed into full blown chicken pox. Follow up information from the registered nurse indicated that on the evening of 13-NOV-2007, she developed an itchy rash all over her body. By 15-NOV-2007, it was indicated that she had in excess of approximately 150 spots all over her body, face, and extremities. The itchy feeling was treated with diphenhydramine (BENADRYL). It was indicated that on 17-NOV-2007, therapy was initiated with hydroxyzine (ATARAX) because the itchiness was so bad. It was noted by the reporter that because of the patient's age, the experience was very stressful on her because of body image disturbance. It was indicated that on 19-NOV-2007, she had begun clearing, and was considered to have recovered. There was no laboratory or diagnostic test performed. The mother of the patient mentioned that "chicken pox was going around the patient's school." The patient's vaccination history included on 09-DEC-1995, a first dose of varicella virus vaccine live (Oka/Merck). A product quality complaint was not reported. Additional information is not expected.
Age: 13.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Stress, Varicella
Clinical narrative: Information has been received from a physician and registered nurse concerning a 13 year old 140 lb 64 in white female with spinal asymmetry, and no known allergies or birth defects, who on 06-NOV-2007 at 11:00 hours received a second subcutaneous dose in the right arm of varicella virus vaccine live (Oka/Merck) (lot#658423/1180U). Concomitant vaccination included a first dose intramuscularly in the left arm of hepatitis A vaccine (inactive) (MSD) (lot# 659187/1259U). There was no concomitant medication. There was no reported illness at the time of the vaccinations and no adverse events following prior vaccination. It was reported that on 06-NOV-2007, she developed a mild varicella like rash which persisted and progressed into full blown chicken pox. Follow up information from the registered nurse indicated that on the evening of 13-NOV-2007, she developed an itchy rash all over her body. By 15-NOV-2007, it was indicated that she had in excess of approximately 150 spots all over her body, face, and extremities. The itchy feeling was treated with diphenhydramine (BENADRYL). It was indicated that on 17-NOV-2007, therapy was initiated with hydroxyzine (ATARAX) because the itchiness was so bad. It was noted by the reporter that because of the patient's age, the experience was very stressful on her because of body image disturbance. It was indicated that on 19-NOV-2007, she had begun clearing, and was considered to have recovered. There was no laboratory or diagnostic test performed. The mother of the patient mentioned that "chicken pox was going around the patient's school." The patient's vaccination history included on 09-DEC-1995, a first dose of varicella virus vaccine live (Oka/Merck). A product quality complaint was not reported. Additional information is not expected.
Age: 8.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella
Clinical narrative: Information has been received from a consumer concerning her 8 year old daughter who on 12-NOV-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). On that same day the patient complained of two pimple-like bumps, one on her neck and one on her chin. On 15-NOV-2007, there was a bunch of pimples on the patient's legs, thought to have been a rash due to chlorine (child on swim team). On 17-NOV-2007, the child was taken to a pediatrician who stated that the patient had chickenpox characterized by 18 lesions and a rash that was not itchy or scabby. The pediatrician noted that the patient was no longer contagious (given the timing), and to contact him if the rash worsens. The child does not have any other symptoms and was back at school normally. There did not appear to be any cases at school, but a male child had a rash, was sent home and had not returned. No further information is available.
Sex: F
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from an office manager concerning a female who on 19-NOV-2007 was vaccinated SC with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) inadvertently instead of zoster vaccine live (Oka/Merck). No problems were reported. The reporter confirmed that this was not a case of product confusion. No further details were available. There was no product quality complaint. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information ahs been received from a physician concerning a patient who on 19-NOV-2007 was vaccinated with a dose of varicella virus live (Oka/Merck) instead of zoster vaccine live (Oka/Merck) due to a human error. The patient had no symptoms. No further information was available. There was no product quality complaint. Additional information has been requested.
Age: 12.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 12-year-old male who on 20-AUG-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot # 658198/0854U). On 23-AUG-2007 the patient developed breakthrough chickenpox. At the time of the report the patient's status was unknown. A product quality complaint was not involved. This is one of several reports received from the same source. Additional information has been requested.
Age: 39.0
Sex: F
Vaccine: VARCEL
Symptoms: Antibody test negative
Clinical narrative: Information has been received from a registered nurse concerning a 39-year-old female who in 1995 (12 years ago) was vaccinated with 2 doses of varicella virus vaccine live (Oka/Merck) and now has negative titers. The patient sought medical attention via a phone call with the physician. A product quality complaint was not involved. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Immediate post-injection reaction, Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 4 year old female who on 18-SEP-2007 was vaccinated with her second dose of varicella virus vaccine live (Oka/Merck) (lot# 657789/0731U). On approximately 18-SEP-2007 "shortly after vaccination", the patient experienced breakthrough varicella on her chest and face. It was unknown whether medical attention was sought. The outcome was unknown. There was no product quality complaint. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Initial and follow-up information has been received from a nurse practitioner concerning a 4 year old white male who was vaccinated with his first dose of varicella virus vaccine live (Oka/Merck) (lot# 657754/0782U) in the right ventralis lateralis. The patient developed 7 lesions on his torso 7 days after vaccination. No medical attention was sought. The outcome was unknown. There was no product quality complaint. This is one of three reports from the same source. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema
Clinical narrative: Information has been received from a health professional concerning a 6 year old female who on 26-JUN-2007 was vaccinated subcutaneously with a second dose of varicella virus vaccine live (Oka/Merck) (Lot# 657449/0597U). Subsequently, the patient experienced redness. The patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash
Clinical narrative: Information has been received from a health professional concerning a 6 year old male who on 11-JUN-2007 was vaccinated SC on the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot# 657449/0597U). On 12-JUN-2007, the patient experienced rash on back, neck and arms and itchiness. The patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Information has been received from a health professional concerning an 11 year old female who on 26-JUN-2007 was vaccinated SC on the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657618/0602U). On 28-JUN-2007, the patient developed injection site red, swelling and itching. No medical attention was sought. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a adolescent who in approximately 1995 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In approximately 2007 the patient developed shingles. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a patient who at 12 months of age, was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient developed shingles at a later time. Additional information has been requested.
Age: 7.0
Sex: U
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a physician concerning a 7 year old patient who was vaccinated with a 0.5 mL dose of varicella virus vaccine live (Oka/Merck) (No lot number was provided). On approximately 27-JUL-2007, the patient developed injection site redness and injection site swelling. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. This is one of several reports from the same source. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a physician concerning an approximately 5 year old male who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (Lot unavailable). Subsequently, the patient developed a rash that "looked like shingles." Unspecified medical attention was sought. Recovery status was unknown. There was no product quality complaint. Follow-up information has been received from a registered nurse indicating that the doctor does not remember the name of the child. No further information is available.
Age: 32.0
Sex: M
Vaccine: VARCEL
Symptoms: Pyrexia, Rash vesicular
Clinical narrative: Information has been received from a registered nurse concerning a 29 year old male with who on 23-JUL-2007 was vaccinated with a 0.5ml SC dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On approximately 23-JUL-2007, the patient developed 10 varicella-like lesions on his abdomen and 1 on his neck. Unspecified medical attention was sought. No labs or diagnostic studies were performed. Subsequently the patient was recovering. There was no product quality complaint. Follow-up information has been received from a nurse indicating that the patient was not their patient. Follow-up information has been received from a registered nurse concerning a 32 year old (also reported as 29 year old) white male financial consultant with no drug allergies who on 23-JUL-2007 was vaccinated with his first dose of varicella virus vaccine live (Oka/Merck). In July 2007, the patient developed 24 varicella-like lesions which started on the chest, spread to arms, legs, face and scalp. The patient also experienced a fever of 100 degrees F. In August 2007, after 3 weeks, the patient fully recovered. It was also noted that the patient received a second dose of varicella virus vaccine live (Oka/Merck) 8 weeks after the first dose with no adverse effects. Additional information has been requested.
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Information ahs been received from an office manager concerning a 4 year old patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot number 656572/0115U). It was reported that after receiving the vaccine the patient developed varicella like lesions, less than 50 on the trunk and legs. A lot check has been initiated. Follow up information was received from a health professional requesting a lot check in varicella virus vaccine live (Oka/Merck) (lot number 656572/0115U). This is one report from the same source. Additional information has been requested.
Age: 12.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Information has been received from a health professional concerning a 12 year old female with no allergies who on 27-JUN-2007 was vaccinated SC on right arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657404/0592U). Concomitant therapy included a first IM dose on right arm of Menactra (Lot # U2343AA). There was no illness at the time of vaccination. It was reported that the patient developed redness and rash at injection site. No medical attention was sought. At the time of report the patient had recovered. Additional information has been requested. This is one of several reports received from the same source.
Age: 12.0
Sex: M
Vaccine: MNQ, VARCEL
Symptoms: Injection site erythema, Injection site pruritus, Oedema peripheral
Clinical narrative: Information has been received from a health professional concerning a 12 year old male with no allergies who on 21-JUN-2007 was vaccinated SC on left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657404/0592U). Concomitant therapy included meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) (Lot # U2331AA). There was no illness at the time of vaccination. It was reported that after vaccination the patient had the left arm swollen with quarter size ring-red around the injection site that was itchy. No medical attention was sought. At the time of report the patient had recovered. Additional information has been requested. This is one of several reports received from the same source.
Age: 11.0
Sex: F
Vaccine: TDAP, VARCEL
Symptoms: Erythema, Pain, Swelling
Clinical narrative: Information has been received from a health professional concerning an 11 year old female with no allergies who on 25-JUN-2007 was vaccinated SC on right arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657403/0715U). Concomitant therapy included IM sixth dose on left arm of Adacel (Lot # C269CAA). At the time of vaccination there was no illness. It was reported that the patient developed redness, swelling and pain after vaccination. No medical attention was sought. At the time of report the patient had recovered. Additional information has been requested. This is one of several reports from the same source.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP, VARCEL
Symptoms: Erythema, Induration, Pruritus, Skin warm, Tenderness
Clinical narrative: Information has been received from a health professional concerning a 11 year old white female with no allergies who on 19-JUN-2007 was vaccinated SC on left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot # 657404/0592U). Concomitant therapy included a IM first dose on right arm of meningococcal ACYW conj vaccine (dip toxoid) (MENACTRA) (Lot # U2331AA) and an IM sixth dose on left arm of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (ADACEL) (Lot # C261CAA). There was no illness at the time of vaccination. It was reported that the patient developed a red hard knot that was itchy, warm to touch and slightly tender after vaccination. No medical attention was sought. At the time of report the patient had recovered. Additional information has been requested. This is one of the several reports received from the same source.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Pruritus, Rash, Skin lesion, Varicella
Clinical narrative: Information has been received from a physician concerning a 9-year-old black male with no pertinent medical history or allergies who on 18-JAN-1999 (previously reported as 08-JAN-1999) was vaccinated with a first subcutaneous dose of varicella virus vaccine live (Oka/Merck) a second subcutaneous dose of on 19-JUL-2007 (lot# 657752/0780U) administered in the right arm (there was conflicting information regarding which dose lot # 657752/0780U refers to). On 29-JUL-2007 the patient's mom noticed an itching rash and lesions on scalp and torso. On 30-JUL-2007 the patient was brought to the physician's office and it was noted that the child had lesions on his scalp, face, trunk (front of chest), back, both arms and legs (chickenpox). There was no cough, cold, runny nose or fever. No diagnostic labs were performed. The physician also noted that the patient's sister who is eleven years old had experienced a chicken pox rash (also described as shingles like) three days ago on 27-JUL-2007. The shingles like rash was described as vesicular papular lesions in different stages of evolution, positive scalp, neck, ears, chest, abdomen and buttocks with swelling and erythema. She is currently on her way to recovery with the majority of the lesions scabbing over. At the time of the report the patient's status was unknown. The patient did not return for follow-up visit. No product quality complaint was involved. Additional information has been requested.
Age: 8.0
Sex: U
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a registered nurse within the physician's office concerning an 8 year old patient was vaccinated with the second SC dose of varicella virus vaccine live (Oka/Merck) (no lot number was given). Subsequently, the patient developed an injection site reaction of redness and injection site swelling on the arm where the vaccine was administered. Unspecified medical attention was sought. The patient's recovery status was unknown. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: U
Vaccine: HEPA, MMRV, VARCEL
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Information has been received from a registered nurse concerning a 13 month old premature born female at 34 weeks gestation with a history of allergic rhinitis and no other allergies, who on 30-JUL-2007 at 13:30 was vaccinated with her first SC dose of varicella virus vaccine live (Oka/Merck) (Lot# 657654/0611U) in the left thigh. There was no illness at the time of vaccination. Concomitant vaccinations administered that day at 13:30 included her first SC dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck) upgrade process) (MSD) (Lot# 657782/0612U) in the left thigh and her first IM dose of hepatitis A virus vaccine inactivated (Lot# AHAVB163AB) in he left thigh. Other concomitant drug therapy included Zyrtec prn. It was noted that the patient inadvertently received the dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27-3) (+) varicella virus vaccine live (Oka/Merck upgrade process) (MSD) instead of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) due to human error not product confusion. The patient was not experiencing any known symptoms. No medical attention was sought. No labs or diagnostic studies were performed. There was no product quality complaint. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male with no pertinent medical history or drug allergies, who on 02-MAR-2007 was vaccinate with the first 0.5 mL SC dose of varicella virus vaccine live (Oka/Merck) (Lot# 656070/1492F) in the arm. Concomitant therapy included Zyrtec and montelukast sodium (MSD). On 27-JUL-2007 the patient developed breakthrough chickenpox and presented with 16 insect bite-like lesions all over his body. Unspecified medical attention was sought. No labs or diagnostic studies were performed. Subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Full blood count, Pyrexia, Radioallergosorbent test positive, Rash
Clinical narrative: Information has been received from a physician concerning a 12 month old female with eczema and food allergy and a history of influenza immunization who on 08-JUN-2007 was vaccinated with her 0.5mL SC dose of varicella virus vaccine live (Oka/Merck) (653516/0347F) in the arm. Concomitant vaccinations included a 0.5mL SC dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) (lot# 652483/0148F) in the left arm. There was no illness at the time of vaccination. Prior vaccinations included a dose of influenza virus vaccine (unspecified) (December 2006). On 08-JUN-2007 the patient experienced high fever and rash within 6 hours after vaccination. Unspecified medical attention was sought. Lab diagnostic studies included a complete blood count and rash test-positive for egg. Subsequently on approximately 11-JUN-2007, the patient recovered and was sent to a pediatric allergist. In July 2007, the patient had hives and experienced vomiting after ingestion of whole egg. The patient was treated with Benadryl to resolve symptoms and pediatric epinephrine was prescribed for the egg reaction. There was no product quality complaint. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion
Clinical narrative: Information has been received from a registered nurse concerning a male who on 18-MAY-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck). On 26-MAY-2007, the patient developed lesions. He wasn't seen by the office so the lesions were not confirmed. No further information was available. The patient's sibling experienced chickenpox rash, mildly itchy rash with vesicular and crusting on his upper thigh and trunk following his first dose of vaccination with varicella virus vaccine live (Oka/Merck) (WAES# 0705USA05710). Additional information has been requested.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received from a health professional concerning a 13-year-old male who on 24-JUL-2007 was vaccinated subcutaneously in the left arm with is second dose of varicella virus vaccine live (Oka/Merck) (lot# 654282/0776U). On 26-JUL-2007, the patient experienced a red, swollen area at the injection site. No medical attention was sought. No outcome was reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 11.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Skin warm
Clinical narrative: Information has been received from a health care worker concerning an 11-year-old female who on 17-JUL-2007 was vaccinated subcutaneously in the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot# 654282/0776U). On 19-JUL-2007, the patient experienced a red, hot to touch area the size of a"playing card". No medical attention was sought. The outcome was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site pain, Injection site urticaria, Injection site warmth
Clinical narrative: Information has been received from a health professional concerning a 6-year-old female who on 16-JUL-2007 was vaccinated subcutaneously in the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot# 654282/0776U). On 17-JUL-2007, the patient developed a warm, red welt 1 1/2 inches in diameter, and soreness at the injection site. No medical attention was sought. No outcome was reported. This is one of several reports from the same reporter. Additional information has been requested.
Age: 13.0
Sex: M
Vaccine: VARCEL
Symptoms: Erythema, Swelling
Clinical narrative: Information has been received concerning a 13 year old male who on 16-JUL-2007 was vaccinated subcutaneously in the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (Lot#654282/0776U). On 17-JUL-2007, the patient developed redness and swelling. No further information was provided. Additional information has been requested. This is one of several reports from the same source.
Age: 11.0
Sex: M
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Information has been received concerning an 11 year old male who on 24-JUL-2007 was vaccinated subcutaneously in the right arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot#654282/0776U). On 26-JUL-2007, the patient developed a red and swollen injection site. No further information was provided. Additional information has been requested. This is one of several reports from the same source.
Age: 9.0
Sex: M
Vaccine: VARCEL
Symptoms: Abdominal pain, Immediate post-injection reaction, Swelling, Urticaria, Vomiting
Clinical narrative: Information has been received concerning a 10 year old male who on 30-JUL-2007 was vaccinated subcutaneously in the left arm with a second dose of varicella virus vaccine live (Oka/Merck) (lot#658056/0835U). On 30-JUL-2007 immediately after receiving the vaccine the patient developed hives all over, vomiting and swelling which required treatment with Benadryl and Solu-Medrol. No other information was provided. Follow up information received indicated that the patient also had abdominal pain. The patient recovered after 2 hours. Additional information is not expected. This is one of several reports from the same source.
Age: 2.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Blister, Body temperature increased, Pyrexia
Clinical narrative: Information has been received from a physician concerning a 25 month old male who on 27-JUL-2007 was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck) (Lot# 652555/1023R). Concomitant therapy included a second dose of hepatitis A vaccine (inactive) (MSD) (Lot# 656993/0001U). On 29-JUL-2007, the patient developed a 105.2 degree fever after vaccination. On 30-JUL-2007, the patient also developed two blisters on his arm at 7:30 morning and evening. On 31-JUL-2007 the patient's temperature was from 101.4 to 102.9 degrees. Unspecified medical attention was sought. Subsequently, the patient was noted to be recovering. There was no product quality complaint. Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: MMR, VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a health professional concerning a 4-year-old male with reactive airways disease and attention deficit/hyperactivity disorder and a history of myringotomy with no known drug allergies, who on 12-AUG-2003 was vaccinated subcutaneously in the left arm with a 0.50 milliliter dose of varicella virus vaccine live (Oka/Merck) (lot# 644721/0018N). Concomitant vaccination included measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) given in a separate site. On 29-JUL-2007, the patient developed chickenpox. There was a rash with less than 50 papular lesions over the whole body that were itchy. The patient was seen in the office on 30-Jul-2007 and at the time some of the lesions were crusting and the patient was afebrile. No laboratory or diagnostic tests were performed. The outcome is reported as recovering. No product quality control complaint was involved. Follow-up information has been received concerning a male. The concomitant vaccination of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) (lot# 644585/1015M) was administered subcutaneously in the right arm. There was no illness at the time of vaccination. On 28-Jul-2007, (previously reported as 29-Jul-2007) the patient developed 75 scattered lesions on trunk, scalp and back. On 30-Jul-2007, the patient was seen in the office and some of the lesions had crusted over. Benadryl was given. On an unknown date the patient recovered. Additional information has been requested.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Pruritus, Swelling, Tenderness
Clinical narrative: Information has been received concerning a 10 year old female who on 14-MAY-2007 was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) (lot#656572/0115U). There was no concomitant medication. On 15-MAY-2007, the patient developed a red swollen area, which was very itchy and tender. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no other information provided. Additional information has been requested. This is one of several reports from the same source.
Age: 11.0
Sex: U
Vaccine: VARCEL
Symptoms: Erythema, Induration
Clinical narrative: Information has been received from a health professional concerning an 11 year old patient who on 07-JUN-2007 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot# 657406/0516U). On 08-JUN-2007, the patient experienced an area of 6.5cm X 6.5cm, mild erythema and induration. Medical attention was sought, patient was treated with Keflex. Subsequently, the patient recovered from mild erythema and induration. No product  quality complaint was involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 5 year old male who in approximately 2003 was vaccinated with the first dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient developed 50 breakthrough lesions or less. Unspecified medical attention was sought. Subsequently, the patient recovered. There was no product quality complaint. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Incorrect route of drug administration, Pain in extremity
Clinical narrative: Information has been received from a nurse concerning a male who on 26-JUL-2007 was vaccinated with varicella vaccine live (Oka/Merck). On 27-JUL-2007, the patient developed a sore left arm. The nurse mentioned the patient was given the vaccine may have got the varicella virus vaccine live IM instead of SQ. The nurse stated she would try to confirm this with the administering nurse. The patient sought unspecified medical attention. The reporting nurse called back and stated that she had spoken with the administering nurse and that there was no adverse event. The nurse reported that she misunderstood a message that was left for her by another nurse. Subsequently, the patient recovered. Further information has been received. The nurse called back and stated she has no further information regarding this patient. In addition she noted that there was no child involved in this report. Additional information is not expected.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Cellulitis, Injection site erythema, Injection site induration, Injection site swelling, Muscular weakness
Clinical narrative: Information has been received from a nurse concerning a 10 year old female who on 17-JUL-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 656079/1306F). On 18-JUL-2007 the patient developed a rash all over, a four inch round red spot around the injection site, a fever of 99-100, and weakness, especially in her legs. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested. Follow-up information received stated that the patient was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) on 18-JUL-2007 in the left arm. There was no illness at the time of vaccination. On 18-JUL-2007, the patient developed a 3X3 indurated area that was red and swollen at the injection site. The patient complained of weakness in the legs, and achy arms. Cellulitis developed and the patient was treated with cephalexin (KEFLEX) 500mg three times a day. The patient did not have a rash. No laboratory or diagnostic tests were performed. Subsequently, the patient recovered.
Age: 10.0
Sex: F
Vaccine: VARCEL
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Information has been received from a nurse concerning a 10 year old female who on 17-JUL-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot # 656079/1306F). On 18-JUL-2007 the patient developed a rash all over, a four inch round red spot around the injection site, a fever of 99-100, and weakness, especially in her legs. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested. Follow-up information received stated that the patient was vaccinated with a second dose of varicella virus vaccine live (Oka/Merck) on 18-JUL-2007 in the left arm. There was no illness at the time of vaccination. On 18-JUL-2007, the patient developed a 3X3 indurated area that was red and swollen at the injection site. The patient complained of weakness in the legs, and achy arms. Cellulitis developed and the patient was treated with cephalexin (KEFLEX) 500mg three times a day. The patient did not have a rash. No laboratory or diagnostic tests were performed. Subsequently, the patient recovered.
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Herpes zoster
Clinical narrative: Information has been received from a physician concerning a 10 year old male, with no pertinent medical history, drug reactions or allergies, who at 15 months of age, on 25-JUN-1998, was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot # 625375/0065H). There was no concomitant medication. In approximately 2006, at nine years of age, the patient developed shingles. In 2007, at ten years of age, the patient developed a second episode of shingles. The shingles was treated with acyclovir. The duration of the episode was one week. The shingles rash was described as covering the shoulder and on the neck. At the time of reporting the patient was considered to be "recovering". Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a physician concerning a 5 year old male who was vaccinated on an undisclosed date with 0.5mL of varicella virus vaccine live (Oka/Merck) and subsequently "had a break through" and developed varicella after receiving varicella virus vaccine live (Oka/Merck). At the time of reporting the patient's status was unknown. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV4, VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a physician concerning a 13 year old female who on 30-JUL-2007 was vaccinated with 0.5 mL of varicella virus vaccine live (Oka/Merck). Concomitant therapy that same day included human papillomavirus vaccine. On 30-JUL-2007, one half hour after receiving both varicella virus and human papillomavirus vaccine, the patient broke out in hives. Unspecified medical attention was sought. There was no product quality complaint. No lot numbers provided. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Urticaria
Clinical narrative: Information has been received from a licensed practical nurse concerning a patient who, on an undisclosed date, was vaccinated with varicella virus vaccine live (Oka/Merck) (Lot # 657109/0444U), and subsequently developed a non vesicular welt. Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: Information has been received from a health professional concerning a 4 year old female who on 25-JUL-2007 was vaccinated subcutaneously into right thigh with a first dose of varicella virus vaccine live (Oka/Merck) (Lot # 657757/0641U), a fourth dose of diphtheria toxoid (+) pertussis acellular I-component vaccine (+) poliovirus vaccine inactivated (Vero) (+) tetanus toxoid, intramuscularly into the right thigh (GSK) (Lot # AC14B046AA), a first dose, into the left thigh, of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot # 656038/0204U) and a third dose, subcutaneously into the left thigh, of poliovirus vaccine inactivated (unspecified) (SP) (Lot # Z1069). On 27-JUL-2007 the patient developed a two inch raised red hard area at the injection site on the right thigh. At the time of reporting the patient's status was unknown. Unspecified medical attention was sought. There was no product quality complaint. Additional information is not expected.
Age: 9.0
Sex: F
Vaccine: HEPA, VARCEL
Symptoms: Blister, Erythema, Induration, Pain, Swelling
Clinical narrative: Information has been received from a health professional concerning a 9 year old female who on 24-JUL-2007 was vaccinated subcutaneously into the right deltoid with a second dose, "booster shot" of varicella virus vaccine live (Oka/Merck) (Lot # 657757/0641U). Concomitant therapy included a first dose of hepatitis A vaccine (inactive) GSK) (Lot # AHAVB1634B), intramuscularly into the left arm. On 24-JUL-2007, the patient developed a 3 cm vesicular area right upper arm, with a 9 X 12 cm surrounding red, hard, painful, swollen area around the blister. The patient was started on (on an undisclosed date) amoxicillin (+) Augmentin. As of 27 JUL 2007 the patient was reported as doing better. There was no product quality complaint. Additional information is not expected.